Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Daily Digest.
Press releases published on April 16, 2025
The Columbus Organization Awarded HCBS Case Management Contract in Vermont
GlobeNewswire
·
April 16, 2025
BLUE BELL, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- The Columbus Organization, the nation’s leading provider of outcomes-based care coordination services for individuals with intellectual/developmental disabilities (IDD), conditions associated with aging, …
Axalta Wins 2025 Automotive News PACE Pilot Award
GlobeNewswire
·
April 16, 2025
PHILADELPHIA, April 16, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems (AXTA), a leading global coatings company, announced today that the digital paint technology Axalta NextJet™ was named a 2025 Automotive News PACE Pilot Innovation to Watch. The …
SECURITIES FRAUD CLASS ACTIONS HAVE SURVIVED MOTIONS TO DISMISS: Long-Term Shareholders of Driven Bands Holdings, Inc. (NASDAQ: DRVN); Maison Solutions Inc. (NASDAQ: MSS); Mercury Systems, Inc. (NASDAQ: MRCY); and Virtu Financial Inc. (NASDAQ: VIRT)…
GlobeNewswire
·
April 16, 2025
PHILADELPHIA, April 16, 2025 (GLOBE NEWSWIRE) -- Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Driven Brands Holdings, Inc. (NASDAQ: DRVN) has survived defendants’ …
New Jersey Turnpike Authority Affirms its Selection of TransCore to Improve E-ZPass Services
GlobeNewswire
·
April 16, 2025
NASHVILLE, Tenn., April 16, 2025 (GLOBE NEWSWIRE) -- TransCore, a leading provider of advanced tolling and traffic management solutions, announced today that the New Jersey Turnpike Authority (NJTA) has affirmed its decision to award TransCore E-ZPass …
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
GlobeNewswire
·
April 16, 2025
CONSHOHOCKEN, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that …